Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin
Clinical trial NCT03760991 · COMPLETED
Trial details
- NCT number
- NCT03760991
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2020-09-23
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.